Pharmacology Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Pharmacology stocks.

Pharmacology Stocks Recent News

Date Stock Title
May 23 JNJ ADHD diagnoses increasing, becoming an 'expanding public health concern': CDC
May 23 NOTV Inotiv, Inc. to Participate in Upcoming Craig Hallum and Jefferies Investor Conferences
May 23 HBIO Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024
May 23 JNJ Biden Administration Urges Supreme Court Review in Terrorism Funding Lawsuit Against Pharma Companies
May 23 JNJ ASCO24: An early look at cancer drug study results
May 23 JNJ Johnson & Johnson: Vital Signs Decent, A Compelling Value Case
May 23 JNJ J&J faces lawsuit over talc-related bankruptcy filings
May 22 JNJ Is Eli Lilly and Company the Largest Publicly Traded Healthcare Company?
May 22 JNJ Cancer victims sue Johnson & Johnson over 'fraudulent' bankruptcies
May 22 JNJ Top Midday Stories: US Targets August 1 Start Date for China Tariff Hikes; CFPB Says BNPL Requires Credit Card-Level Oversight; Target Shares Fall on Earnings Miss; Third BHP Bid Rejected by Anglo American
May 22 JNJ J&J’s Tremfya superior to Stelara in Phase II/III Chron’s disease trials
May 22 MLAB Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results to May 31, 2024
May 21 ICLR At US$319, Is ICON Public Limited Company (NASDAQ:ICLR) Worth Looking At Closely?
May 21 JNJ Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Johnson & Johnson Stock
May 21 JNJ J&J’s Tremfya meets endpoints in Phase III ulcerative colitis trial
May 20 JNJ Johnson & Johnson's Tremfya meets goals in late-stage trial for ulcerative colitis
May 20 JNJ Pulsed field ablation poised for fast adoption, analysts say
May 20 JNJ J&J posts latest Varipulse data while awaiting FDA review
May 20 ICLR ICON plc to hold Investor Day Meeting on May 30, 2024
May 19 JNJ Biopharma M&A surges year over year in Q1
Pharmacology

Pharmacology is the branch of biology concerned with the study of drug action, where a drug can be broadly defined as any man-made, natural, or endogenous (from within the body) molecule which exerts a biochemical or physiological effect on the cell, tissue, organ, or organism (sometimes the word pharmacon is used as a term to encompass these endogenous and exogenous bioactive species). More specifically, it is the study of the interactions that occur between a living organism and chemicals that affect normal or abnormal biochemical function. If substances have medicinal properties, they are considered pharmaceuticals.
The field encompasses drug composition and properties, synthesis and drug design, molecular and cellular mechanisms, organ/systems mechanisms, signal transduction/cellular communication, molecular diagnostics, interactions, toxicology, chemical biology, therapy, and medical applications and antipathogenic capabilities. The two main areas of pharmacology are pharmacodynamics and pharmacokinetics. Pharmacodynamics studies the effects of a drug on biological systems, and Pharmacokinetics studies the effects of biological systems on a drug. In broad terms, pharmacodynamics discusses the chemicals with biological receptors, and pharmacokinetics discusses the absorption, distribution, metabolism, and excretion (ADME) of chemicals from the biological systems. Pharmacology is not synonymous with pharmacy and the two terms are frequently confused. Pharmacology, a biomedical science, deals with the research, discovery, and characterization of chemicals which show biological effects and the elucidation of cellular and organismal function in relation to these chemicals. In contrast, pharmacy, a health services profession, is concerned with application of the principles learned from pharmacology in its clinical settings; whether it be in a dispensing or clinical care role. In either field, the primary contrast between the two are their distinctions between direct-patient care, for pharmacy practice, and the science-oriented research field, driven by pharmacology.
The origins of clinical pharmacology date back to the Middle Ages in Avicenna's The Canon of Medicine, Peter of Spain's Commentary on Isaac, and John of St Amand's Commentary on the Antedotary of Nicholas. Clinical pharmacology owes much of its foundation to the work of William Withering. Pharmacology as a scientific discipline did not further advance until the mid-19th century amid the great biomedical resurgence of that period. Before the second half of the nineteenth century, the remarkable potency and specificity of the actions of drugs such as morphine, quinine and digitalis were explained vaguely and with reference to extraordinary chemical powers and affinities to certain organs or tissues. The first pharmacology department was set up by Rudolf Buchheim in 1847, in recognition of the need to understand how therapeutic drugs and poisons produced their effects.Early pharmacologists focused on natural substances, mainly plant extracts. Pharmacology developed in the 19th century as a biomedical science that applied the principles of scientific experimentation to therapeutic contexts. Today pharmacologists use genetics, molecular biology, biochemistry, and other advanced tools to transform information about molecular mechanisms and targets into therapies directed against disease, defects or pathogens, and create methods for preventative care, diagnostics, and ultimately personalized medicine.

Browse All Tags